Download Accel-Heal® at a glance commissioners

Accel-Heal at a glance
®
commissioners
What is Accel-Heal?
Accel-Heal is a certified and patented, electroceutical treatment
device (Class IIA) designed to improve and accelerate healing
rates in patients with complex wounds.
What is an electroceutical?
Practically all of the body’s organs and functions are regulated
through neural circuits communicating via electrical impulses,
it is therefore possible to interpret the electrical language
of disease from the level of gene expression upwards.
By extension, it is then possible to stimulate, inhibit or change
a malfunctioning pathway in order to correct the defect.
The new term for this innovative area of medicine is
electroceutical. Unlike the universal term previously used,
‘e-stim’, electroceutical implies a more accurately targeted
application more akin to its pharmaceutical equivalent.
Synapse – Accel-Heal’s parent company is leading the way
in this area of medicine with the development of a clinically
relevant electroceutical with its patented Synapse Sequence
found within the compact Class IIA device Accel-Heal.
What is Accel-Heal used for?
Accel-Heal is to be used to treat any complex wound alongside
standard care.
How long is the treatment?
Accel-Heal is a 12 day treatment course, consisting of six pre
programmed, battery powered 48 hour single use units, applied
consecutively.
How big is Accel-Heal?
Accel-Heal is much smaller and portable than any other available
treatment device (7cm x 4cm x 2cm).
How does Accel-Heal work?
Neural circuits communicating via electrical impulses regulate
many physiological functions, therefore it is possible to interpret
the electrical language of health and disease from the level of
gene expression upwards. It is now possible to inhibit or change
a malfunctioning electrical pathway in order to correct a potential
defect. Accel-Heal is a non invasive, compact Class IIA medical
device which uses the patented Synapse Sequence programmed
to deliver a specific series of electric energy interactions through the
skin to manipulate gene expression to modify specific physiological
functions in dermal tissue.
Why should I commission the purchase of
Accel-Heal?
With more emphasis on outcomes based commissioning,
requiring commissioners and clinicians to deliver better
outcomes at lower costs Accel-Heal helps as it improves
and accelerates positive outcomes for patients with complex
wounds, while significantly contributing to cost savings:
95% clinical efficacy
cost per QALY of minus £7,696*
27% reduction in nurse visits
*QALY is a unit of ‘treatment’ cost being a measure of disease burden including both the quality and quantity of life
lived. Each drug or treatment is considered on a case-by-case basis. Generally, if a treatment costs more than
£20,000-30,000 per QALY, then it would not be considered to be cost effective. A treatment with a minus cost per
QALY figure saves both money and improves the patient outcome over and above the current treatment or drug.
Why should clinicians use Accel-Heal?
At Synapse – the home of Accel-Heal we know that every wound has
the potential to become complex. Accel-Heal brings clinicians a tool to
heal wounds before they become complex, as well as a long awaited
breakthrough to healing those that have already become non-healing.
Reducing the impact of wounds on patients through accelerating healing,
reducing pain and exudate, Accel-Heal also reduces costs for wound care
providers by cutting down healing times and resources such as nursing
visits, dressings and analgesia. With a 95% clinical efficacy recorded in
clinical trials, developed to provide ease and simplicity of clinical application
Accel-Heal improves and accelerates healing rates, while significantly
contributing to cost savings with its cost per QALY of minus £7,696
(reduction of 15% to NHS costs) and a 27% reduction in nurse visits.
How to use Accel-Heal?
Each Accel-Heal treatment course consists of six, battery powered 48
hour single use units (to be applied consecutively) and electrodes pads.
The pads should be applied to healthy skin either side of the wound and
then connected to the Accel-Heal unit, during a standard care procedure
(dressing change). The unit is then activated using an on / off switch, tucked
into the external dressing, and left to work for 48 hours. Once the 48 hour
dose of treatment has finished, the unit will automatically turn itself off. A new
unit is then attached to the electrodes, with the used unit disposed of safely.
The effectiveness of Accel-Heal
100%
75%
57%
50%
38%
25%
5%
0%
Healed
Improved
0%
Worsened No change
>95% efficacy recorded in clinical trials
>38% complete healing rate recorded for Accel-Heal versus only
9% for compression bandaging alone
>27% reduction in nurse visits, 15% reduction in treatment costs
and a cost per QALY of minus £7,696
Find out more
To find out more about Accel-Heal visit www.accelheal.com
To find out more about Synapse – The home of Accel-Heal visit
www.synapseelectroceutical.com
Arrange an educational visit
To arrange a non promotional visit to find out more about
Accel-Heal, email us on [email protected]
or call us on 01959 569 433
Purchase Accel-Heal
Please contact us at [email protected]
or call us on 01959 569 433
NHS Supply Chain
Accel-Heal is available via NHS Supply Chain and SBS Services,
Product Code: K560-6
Synapse Electroceutical Ltd
1 Churchill Court, Hortons Way, Westerham, Kent, TN16 1BT
t: 01959 569 433 e:[email protected]
www.synapseelectroceutical.com
Company reg.no: 04626631